| CYHS2501685 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2025-05-09 | | Guangdong Zhongsheng Pharmaceutical Co Ltd | | | view |
| CYHS2501346 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2025-04-09 | | Chengdu Push Pharmaceutical Co Ltd | | | view |
| CYHB2500558 | 富马酸依美斯汀缓释胶囊 | emedastine difumarate | Capsules, extended release | Chemical Drugs(3) | Supplementary Application | 2025-03-18 | | Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| CYHS2500349 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2025-01-17 | | Guangzhoudaguang Pharmaceutical Co Ltd | | | view |
| CYHS2404471 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2024-12-24 | | Nanjing Healthnice Pharmaceutical Co Ltd | | | view |
| CYHS2404335 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2024-12-13 | | Shijiazhuang NO4 Pharmaceutical Co Ltd | | | view |
| CYHS2402858 | 富马酸依美斯汀缓释胶囊 | emedastine difumarate | Capsules, extended release | Chemical Drugs(3) | Generic Drug | 2024-08-31 | | Hunan Common Medicine Technology Co Ltd;Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| CYHS2402051 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2024-07-06 | | Wuhan Wujing Pharmaceutical Co Ltd;Nanjing H&D Pharmaceutical Technology Co Ltd | | | view |
| CYHS2401666 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2024-06-04 | | Renheng Pharm Limited;Hefei Huawei Pharmaceutical Co Ltd | | | view |
| CYHS2401321 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs(4) | Generic Drug | 2024-04-30 | | Zhejiang Shifangji Pharmaceutical Technology Co Ltd;Zhejiang Shapuaisi Pharmaceutical Co Ltd | | | view |
| JYHZ2300448 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | License Renew | 2023-12-06 | | SA Alcon-Couvreur NV;Future Health Pharma GmbH;Ocumension Therapeutics(Suzhou)Co Ltd | | | view |
| CYHB2350500 | 富马酸依美斯汀缓释胶囊 | emedastine difumarate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2023-06-16 | | Defengyaoye | | | view |
| CYHB2202058 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2022-11-11 | | Ocumension Therapeutics(Suzhou)Co Ltd | | | view |
| JYHB2200193 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2022-04-11 | | Future Health Pharma GmbH;SA Alcon-Couvreur NV | | | view |
| JYHB2100058 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2021-01-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Pharma Schweiz AG | Certificate Issued | 2021-02-01 | view |
| JTH2000343 | 富马酸依美斯汀 | emedastine difumarate | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-11-24 | Laboratori Alchemia S.r.l. | Laboratori Alchemia Srl;Liaoning Green Biological Pharmaceutical Group Co Ltd | Certificate Issued | 2020-12-17 | view |
| JYHB2002020 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2020-10-15 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd | Filed | 2020-11-05 | view |
| JYHB2000819 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2020-06-12 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd | Filed | 2020-06-19 | view |
| JYHZ1900078 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | License Renew | 2019-03-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd | Certificate Issued | 2019-11-14 | view |
| JYHB1801317 | 富马酸依美斯汀滴眼液 | emedastine difumarate | Eye drops | Chemical Drugs | Supplementary Application | 2018-11-16 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd | Certificate Issued | 2019-03-11 | view |
